Omari Jones-Nelson - Concepedia

Author

Omari Jones-Nelson

AstraZeneca (United States)

Also Known As

O. Jones-Nelson, Omari Jones-Nelson

Publications

458

Citations

H-Index

Concepts

All Affiliations

AstraZeneca (United States)

About

Omari Jones-Nelson is an author at AstraZeneca (United States) specializing in medicine, microbiology, and infection control.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	124
2	Immunology	3	3	110
3	Health Sciences	2	2	69
4	Biology	1	1	14
5	Diabetes	1	1	41

Omari Jones-Nelson

Publications

458

Citations

H-Index

Page 1

	Year	Citations
<i>Staphylococcus aureus</i> α toxin potentiates opportunistic bacterial lung infections Taylor S. Cohen, Jamese J. Hilliard, Omari Jones-Nelson, Science Translational Medicine	2016	119
S. aureus Evades Macrophage Killing through NLRP3-Dependent Effects on Mitochondrial Trafficking Taylor S. Cohen, Michelle L. Boland, Brandon B. Boland, Cell Reports	2018	92
Anti-Alpha-Toxin Monoclonal Antibody and Antibiotic Combination Therapy Improves Disease Outcome and Accelerates Healing in a Staphylococcus aureus Dermonecrosis Model Jamese J. Hilliard, Vivekananda Datta, Christine Tkaczyk, Antimicrobial Agents and Chemotherapy Antibiotic AdjuvantImmunologyAntimicrobial ChemotherapyDermatologyImmunotherapy	2014	53
S. aureus blocks efferocytosis of neutrophils by macrophages through the activity of its virulence factor alpha toxin Taylor S. Cohen, Omari Jones-Nelson, Meghan Hotz, Scientific Reports	2016	41
Staphylococcus aureus drives expansion of low-density neutrophils in diabetic mice Taylor S. Cohen, Virginia Takahashi, Jessica Bonnell, Journal of Clinical Investigation Microbial PathogensInnate Immune SystemImmunologyImmune RegulationPathology	2019	41
Multimechanistic Monoclonal Antibodies (MAbs) Targeting Staphylococcus aureus Alpha-Toxin and Clumping Factor A: Activity and Efficacy Comparisons of a MAb Combination and an Engineered Bispecific Antibody Approach Christine Tkaczyk, Srinath Kasturirangan, Andrea Minola, Antimicrobial Agents and Chemotherapy	2017	38
Neutralizing Staphylococcus aureus Virulence with AZD6389, a Three mAb Combination, Accelerates Closure of a Diabetic Polymicrobial Wound Christine Tkaczyk, Omari Jones-Nelson, Yue Shi, mSphere	2022	28
The Neutrophilic Response to <i>Pseudomonas</i> Damages the Airway Barrier, Promoting Infection by <i>Klebsiella pneumoniae</i> Omari Jones-Nelson, Jamese J. Hilliard, Antonio DiGiandomenico, American Journal of Respiratory Cell and Molecular Biology	2018	16
Antibacterial Monoclonal Antibodies Do Not Disrupt the Intestinal Microbiome or Its Function Omari Jones-Nelson, Andrey Tovchigrechko, Matthew S. Glover, Antimicrobial Agents and Chemotherapy DysbiosisHost-microbe InteractionsImmunologyIntestinal MicrobiomeBroad-spectrum Antibiotics	2020	16
Transmission dynamics of two strains of Schistosoma mansoni utilizing novel intermediate and definitive hosts Omari Jones-Nelson, Elizabeth A. Thiele, Dennis J. Minchella Parasitology Research BiologySchistosoma MansoniTransmission DynamicsParasitic DiseaseSchistosomiasis	2011	14

Page 1